Clincosm LogoSign in Get a demo

prostate cancer

Showing NaN - NaN of 180
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Worldwide (Abemaciclib, Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +116 more
Aug 17, 2022

Prostate Cancer Trial in Houston (Interviews, Surveys)

Not yet recruiting
  • Prostate Cancer
  • Interviews
  • Surveys
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Prostate Cancer Trial in Houston (Focal Cryoablation, Standard of Care, Quality-of-life Questionnaires)

Recruiting
  • Prostate Cancer
  • Focal Cryoablation
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 26, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Prostate Cancer Trial in Houston (restriction spectrum imaging (RSI))

Not yet recruiting
  • Prostate Cancer
  • restriction spectrum imaging (RSI)
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Prostate Cancer Trial in United States (Invitae multi-cancer gene panel)

Completed
  • Prostate Cancer
  • Invitae multi-cancer gene panel
  • San Diego, California
  • +18 more
Jul 1, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Prostate Cancer Trial in Canada, United States (Casodex, Eulexin, LHRH agonist)

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +260 more
May 23, 2022

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +239 more
May 23, 2022

Prostate Cancer, NSCLC Trial in Worldwide (Isatuximab SAR650984, Cemiplimab REGN2810)

Terminated
Has Results
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Isatuximab SAR650984
  • Cemiplimab REGN2810
  • Birmingham, Alabama
  • +15 more
Apr 21, 2022

Active Surveillance in Prostate Cancer

Completed
  • Prostate Cancer
  • Survey
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2022

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Prostate Cancer Trial in Worldwide (rhPSMA-7.3 (18F) Injection)

Completed
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +33 more
Mar 15, 2022

Prostate Cancer Trial in Finland, Netherlands, United States (rhPSMA-7.3 (18F) Injection)

Completed
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +27 more
Mar 15, 2022

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Prostate Cancer Trial in Houston (Alpharadin)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 16, 2022

Prostate Cancer, Prostate Nodule Trial in Houston (18F-fluciclovine)

Not yet recruiting
  • Prostate Cancer
  • Prostate Nodule
  • 18F-fluciclovine
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Feb 14, 2022

Breast Cancer, Head and Neck Squamous Cell Carcinoma, Colorectal Cancer Trial in Philadelphia, Dallas, Houston (ONM-100)

Completed
  • Breast Cancer
  • +6 more
  • Philadelphia, Pennsylvania
  • +2 more
Feb 9, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Liposarcoma, CRC, Prostate Cancer Trial in United States (PF-07220060, Letrozole, Fulvestrant)

Recruiting
  • Liposarcoma
  • +5 more
  • New Haven, Connecticut
  • +8 more
Jan 20, 2022